Formulations

NATCO has pioneered the delayed acting timed release dosage preparation in India which remains the company's forte. Its world class pharma facilities at Kothur, India which is an ISO-9002 certified plant is capable of manufacturing formulations to International standards using this technology. Tablets, capsules, liquids, dry powder for suspensions, aerosols etc. are manufactured with utmost care and quality consciousness. 

Time Cap Pharma Labs located at Kothur, India one of the group companies of NATCO manufactures specialty formulations exclusively for leading pharmaceutical companies of India.

NATCO has modern facilities and very strong capabilities to manufacture comprehensive range of finished dosage forms including various oral solids, liquids, inhalers and parenterals with delayed, rapid and sustained acting, aerosols and transdermal mechanisms for drug delivery. 

Drug Delivery Systems 

NATCO's facilities have always succeeded in commercial scale-ups of its innovations in dosage delivery systems.The first to pioneer Timed Release Dosage Systems in India, NATCO has also done path-breaking work with other drug delivery. systems like nanosphere / microsphere technology, aerosols and transdermal patches for a variety of drugs. 

Formulations and Brand Building 

NATCO has proven expertise in formulations that achieve most effective therapeutic results and patient compliance.They earned NATCO tremendous goodwill and trust among the medical fraternity. 

In the aftermath of the business process reengineering NATCO is set to launch a wide range of new generation formulations in both prescription and OTC categories in various categories such as antibiotics, anti-malarial, anti-anginal, analgesics, anti-pyretic, peripheral vasodilators, amoebicides, anti-hypertensives, anti-asthmatics, anti-epileptics, tranquilizers, anti-depressants, oncologicals, anti-emetics and nutritional supplements. Noted for their sustained quality, NATCO’s brands have instant recall and are represented in all therapeutic segments. 

Generics 

Generic version of various prescription drug make healthcare more accessible and affordable. NATCO offers a basket of such products to certain markets in India where cost - effective therapeutics form a necessity.

 
NATCO confirms filing of ANDA for Generic Revlimid 31/08/2010
NATCO denies speculative news 23/08/2010
NATCO reports increased earnings and profits 31/07/2010
NATCO launches Anastrazole in the USA 29/06/2010
NATCO records higher sales, profits 25/06/2010
NATCO launches BENDIT 07/04/2010
NATCO declares an interim dividend of Rs. 2 per share 27/01/2010
Press Release 09/01/2010
NATCO records increase in revenues, profits 29/10/2009
Natco’s note on anti-cancer drug Albupax 19/10/2009
NATCO Pharma launches Swine Flu medicine 18/09/2009
NATCO’s partner – Mylan’s – ANDA accepted for review of Glatiramer Acetate 14/09/2009
News | Careers | Privacy Policy
NATCO House, Road No: 2, Banjara Hills, Hyderabad - 500 033
Powered by www.sholay.in